Lymphangioleiomyomatosis (LAM) is a rare cystic lung disease primarily affecting women, driven by TSC1 or TSC2 mutations that lead to constitutive mTORC1 activation and progressive respiratory failure. This evidence concerns the gene TSC1 and lymphangioleiomyomatosis.